New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...

Add Yahoo as a preferred source to see more of our stories on Google. Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts.

Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts. This innovative treatment, an immunotherapy designed to harness the ...

FCancer, a non-profit focused on cancer prevention and early detection, has declared its mission to “beat cancer off, ...

A study found microplastics in prostate tumors, with higher levels in cancer tissue, prompting further research into ...

Prostate cancer screening plans could be scaled back even further, despite growing calls for more testing to be rolled out.

Prostate cancer is the second most common cancer in US men, after skin cancer, as roughly 1 in 8 men will be diagnosed in ...

For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...

Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...

By partnering with other like-minded organizations to fund targeted RFAs throughout the year, ACS is able to invest in new ...